Clinical Trials Browser

Phase 4 × OTHER × pegylated granulocyte colony-stimulating factor × Clear all

NCT07101445 2026-02-10

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Phase 4 Recruiting

Multiple Myeloma

NCT03844360 2025-03-30

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Phase 4 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT03858166 2024-01-05

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

Phase 4 Terminated

Ovarian Neoplasms

NCT06026995 2023-09-07

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

Phase 4 Unknown

Lymphoma

NCT04009941 2020-10-28

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Phase 4 Completed

Breast Neoplasms, Neutropenia

NCT02944604 2019-01-18

The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Phase 4 Completed

Breastcancer

NCT03206684 2017-08-28

To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer

Phase 4 Unknown

Uterine Cervical Neoplasms

NCT02905942 2016-09-19

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Phase 4 Unknown

Lymphoma